Genetic and Pharmacological Validation of CRMP2 Phosphorylation as a Novel therapeutic Target for Neuropathic Pain
$796,630R01FY2020NSNIH
New York University, New York NY
Investigators
Linked publications, trials & patents
Paper 39233208Paper 38948724Paper 38895294Paper 38894876Paper 38766071Paper 38595206Paper 37862053Paper 37751532Paper 37669398Paper 37498871Paper 37366599Paper 36729125Paper 36687466Paper 36245395Paper 36017978Paper 35029600Paper 34983286Paper 34303780Paper 33478555Paper 33422652Paper 33009246Paper 32773603
View original record on NIH RePORTER →